Spots Global Cancer Trial Database for mifepristone
Every month we try and update this database with for mifepristone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome | NCT01371565 | Cushing's Disea... Cushing's Syndr... | Mifepristone | 18 Years - | Corcept Therapeutics | |
| Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | NCT02014337 | Breast Cancer Ovarian Epithel... Sarcoma Non-small Cell ... Carcinoma, Tran... Prostate Cancer Prostatic Neopl... | Mifepristone an... | 18 Years - | Corcept Therapeutics | |
| The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | NCT00579475 | Uterine Fibroid... | Mifegyne placebo | 18 Years - | Karolinska Institutet | |
| BRCA1/2 and Effect of Mifepristone on the Breast | NCT01898312 | Women With Muta... | Mifepristone | 18 Years - | Karolinska Institutet | |
| TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset | NCT04254627 | Gulf War Illnes... | Etanercept Mifepristone | 45 Years - 70 Years | Nova Southeastern University | |
| A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas | NCT00219778 | Leiomyoma | mifepristone | 25 Years - 49 Years | Poitiers University Hospital | |
| Mifepristone for Patients With Endometrial Cancer and LGESS | NCT00505739 | Endometrial Can... | Mifepristone | - | M.D. Anderson Cancer Center | |
| Trial of Mifepristone for Fibroids | NCT00133705 | Leiomyoma | Mifepristone Inert Capsule | 18 Years - | University of Rochester | |
| Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer | NCT03225547 | Triple Negative... Breast Cancer | Pembrolizumab Mifepristone | 18 Years - | University of Chicago | |
| Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | NCT02014337 | Breast Cancer Ovarian Epithel... Sarcoma Non-small Cell ... Carcinoma, Tran... Prostate Cancer Prostatic Neopl... | Mifepristone an... | 18 Years - | Corcept Therapeutics | |
| Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer | NCT02642939 | Non-Small Cell ... | Mifepristone | 18 Years - | Check, Jerome H., M.D., Ph.D. | |
| Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer | NCT02642939 | Non-Small Cell ... | Mifepristone | 18 Years - | Check, Jerome H., M.D., Ph.D. | |
| Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer | NCT02642939 | Non-Small Cell ... | Mifepristone | 18 Years - | Check, Jerome H., M.D., Ph.D. | |
| S9005 Mifepristone in Meningioma | NCT03015701 | Meningioma | Mifepristone Placebo | 18 Years - 120 Years | SWOG Cancer Research Network | |
| The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | NCT00579475 | Uterine Fibroid... | Mifegyne placebo | 18 Years - | Karolinska Institutet | |
| Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. | NCT05016349 | Breast Cancer F... | All trans-retin... 13-Cis Retinoic... Mifepristone Cannabidiol 9 cis retinoic ... Tamoxifen Standard therap... | 18 Years - 70 Years | Kafrelsheikh University | |
| Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B. | NCT02651844 | Breast Cancer | Mifepristone | - | Hospital Provincial Magdalena V. de Martínez | |
| Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B. | NCT02651844 | Breast Cancer | Mifepristone | - | Hospital Provincial Magdalena V. de Martínez | |
| A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer | NCT06099769 | Metastatic Brea... | Enzalutamide Mifepristone TPC | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer | NCT01138553 | Invasive Breast... Ductal Carcinom... | Mifepristone | 18 Years - | University of California, San Diego | |
| Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. | NCT05016349 | Breast Cancer F... | All trans-retin... 13-Cis Retinoic... Mifepristone Cannabidiol 9 cis retinoic ... Tamoxifen Standard therap... | 18 Years - 70 Years | Kafrelsheikh University | |
| Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids | NCT00886873 | Uterine Fibroid... | Mifepristone | 18 Years - 50 Years | Mediterranea Medica S. L. | |
| Mifepristone for Patients With Endometrial Cancer and LGESS | NCT00505739 | Endometrial Can... | Mifepristone | - | M.D. Anderson Cancer Center | |
| Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome | NCT01371565 | Cushing's Disea... Cushing's Syndr... | Mifepristone | 18 Years - | Corcept Therapeutics | |
| Mifepristone (RU-486) in Androgen Independent Prostate Cancer | NCT00140478 | Prostate Cancer Adenocarcinoma ... | Mifepristone | 18 Years - | Dana-Farber Cancer Institute | |
| Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers | NCT00832871 | Cancer | Mifepristone | 18 Years - | New Mexico Cancer Care Alliance | |
| Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers | NCT00832871 | Cancer | Mifepristone | 18 Years - | New Mexico Cancer Care Alliance | |
| Trial of Mifepristone for Fibroids | NCT00133705 | Leiomyoma | Mifepristone Inert Capsule | 18 Years - | University of Rochester | |
| S9005 Mifepristone in Meningioma | NCT03015701 | Meningioma | Mifepristone Placebo | 18 Years - 120 Years | SWOG Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
